Trial NCT04614636

View at ClinicalTrials.gov 
Org. Study IDs: FT538-101

Last trial update was posted on 2023-09-21

MeSH Interventions

Cyclophosphamide Daratumumab Elotuzumab Fludarabine

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

AML, Adult Acute Myeloid Leukemia Myeloma

Stopping Reasons

This study was terminated by the Sponsor.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID